Pharmacokinetic Properties of Two Dosages Nevirapine Extended Release (XR) Formulations Compared to VIRAMUNE® Tablet as Well as to Nevirapine XR Tablet in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

July 31, 2008

Conditions

Healthy

Interventions

DRUG

Nevirapine XR low dose

DRUG

Nevirapine XR medium dose

DRUG

Nevirapine XR high dose

DRUG

Nevirapine (VIRAMUNE®)